Wellgistics licenses DataVault AI smart contract IP for PharmacyChain; $2.5M upfront plus royalties

Wellgistics Health, Inc.

Upfront license fee of $2.5M due by Dec 31, 2025; ongoing 13% royalty on PharmacyChain net profit.
Minimum annual royalty of $1M from 2028, waived if PharmacyChain net profit under $2M in 2028-2029.
DataVault receives 90% of any sublicensing revenue Wellgistics generates from the licensed IP.
Exclusive license for DataVault's smart contract patents in prescription drug distribution; Wellgistics to build PharmacyChain platform.
Wellgistics expects to integrate with EinsteinRx AI, targeting disruption of PBM rebate system in $634B US drug market.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Wellgistics Health, Inc. entered into License Agreement with DataVault AI Inc. valued at Non-refundable license fee of $2,500,000; royalty fee of 13% on net profit; minimum annual royalty o (effective 2025-11-24).

Action: entry
Agreement: license
Counterparty: DataVault AI Inc.
Value: Non-refundable license fee of $2,500,000; royalty fee of 13% on net profit; minimum annual royalty o
Effective: 2025-11-24

Exact text from the filing

Item 1.01. Entry into a Material Definitive Agreement. On November 24, 2025, Wellgistics Health, Inc. (the “ Company ”), entered into a license agreement (the “ License Agreement ”) with DataVault AI Inc. (“ DataVault ”) pursuant to which DataVault shall license certain intellectual property to the Company which the Company intends to use for purposes of developing manufacturer-to-patient blockchain-enabled smart contracts designed to optimize the Company’s proprietary technology and physical infrastructure for the prescription drug industry (“ PharmacyChainTM ”). The term of the License Agreement shall last for the life of DataVault’s patents underlying the proprietary materials, unless earlier terminated by the parties. In exchange for the license, the Company shall pay DataVault a non-refundable license fee equal to Two Million Five Hundred Thousand Dollars ($2,500,000.00) to be paid by December 31, 2025. The Company will pay DataVault a royalty fee equal to thirteen percent (13%) o

View on SEC.gov

84 material agreements filed in the last 30 days. Browse all material agreements →

Wellgistics Health, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-025072

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.